Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran

Lancet Infect Dis. 2021 May;21(5):602-603. doi: 10.1016/S1473-3099(21)00053-0. Epub 2021 Feb 15.

Authors

Mahan Ghafari¹, Alireza Kadivar², Aris Katzourakis³

Affiliations

¹ Department of Zoology, University of Oxford, Oxford, UK. Electronic address: mahan.ghafari@zoo.ox.ac.uk.
² Center for Statistics and Operation Research, Statsminute, Tehran, Iran.
³ Department of Zoology, University of Oxford, Oxford, UK. Electronic address: aris.katzourakis@zoo.ox.ac.uk.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Viral
COVID-19*
Cities
Cross-Sectional Studies
Humans
Iran / epidemiology
SARS-CoV-2*
Seroepidemiologic Studies

Substances

Antibodies, Viral